
Suzanne E. Ziska
Examiner (ID: 5025, Phone: (571)272-8997 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 2899, 1633, 1632, 1804, 1806, 1614, 1619 |
| Total Applications | 958 |
| Issued Applications | 443 |
| Pending Applications | 48 |
| Abandoned Applications | 468 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4845544
[patent_doc_number] => 20080181952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Perfusive Organ Hemostasis'
[patent_app_type] => utility
[patent_app_number] => 11/954109
[patent_app_country] => US
[patent_app_date] => 2007-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18701
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181952.pdf
[firstpage_image] =>[orig_patent_app_number] => 11954109
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/954109 | Perfusive Organ Hemostasis | Dec 10, 2007 | Abandoned |
Array
(
[id] => 4697880
[patent_doc_number] => 20080220064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'EXTENDED RELEASE MATRIX FORMULATIONS OF MORPHINE'
[patent_app_type] => utility
[patent_app_number] => 11/951885
[patent_app_country] => US
[patent_app_date] => 2007-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3364
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20080220064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11951885
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/951885 | EXTENDED RELEASE MATRIX FORMULATIONS OF MORPHINE | Dec 5, 2007 | Abandoned |
Array
(
[id] => 4431228
[patent_doc_number] => 07968124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 11/951847
[patent_app_country] => US
[patent_app_date] => 2007-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18763
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968124.pdf
[firstpage_image] =>[orig_patent_app_number] => 11951847
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/951847 | Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use | Dec 5, 2007 | Issued |
Array
(
[id] => 6617958
[patent_doc_number] => 20100003328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'BONE FILLER FOR CARTILAGE TISSUE REGENERATION TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/312829
[patent_app_country] => US
[patent_app_date] => 2007-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 5965
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003328.pdf
[firstpage_image] =>[orig_patent_app_number] => 12312829
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/312829 | BONE FILLER FOR CARTILAGE TISSUE REGENERATION TREATMENT | Nov 28, 2007 | Abandoned |
Array
(
[id] => 4764691
[patent_doc_number] => 20080175902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Methods for slowing the progression of multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/998373
[patent_app_country] => US
[patent_app_date] => 2007-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10472
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20080175902.pdf
[firstpage_image] =>[orig_patent_app_number] => 11998373
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/998373 | Methods for slowing the progression of multiple sclerosis | Nov 27, 2007 | Abandoned |
Array
(
[id] => 4845534
[patent_doc_number] => 20080181942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Delta-9-THC compositions and methods for treating symptoms associated with multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/998460
[patent_app_country] => US
[patent_app_date] => 2007-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6062
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181942.pdf
[firstpage_image] =>[orig_patent_app_number] => 11998460
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/998460 | Delta-9-THC compositions and methods for treating symptoms associated with multiple sclerosis | Nov 27, 2007 | Abandoned |
Array
(
[id] => 4898957
[patent_doc_number] => 20080118571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'MODIFIED RELEASE ANALGESIC SUSPENSIONS'
[patent_app_type] => utility
[patent_app_number] => 11/942826
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12148
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118571.pdf
[firstpage_image] =>[orig_patent_app_number] => 11942826
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/942826 | Modified release analgesic suspensions | Nov 19, 2007 | Issued |
Array
(
[id] => 4898930
[patent_doc_number] => 20080118544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'DRUG RELEASING COATINGS FOR MEDICAL DEVICES'
[patent_app_type] => utility
[patent_app_number] => 11/942452
[patent_app_country] => US
[patent_app_date] => 2007-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22372
[patent_no_of_claims] => 160
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118544.pdf
[firstpage_image] =>[orig_patent_app_number] => 11942452
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/942452 | Drug releasing coatings for medical devices | Nov 18, 2007 | Issued |
Array
(
[id] => 8469398
[patent_doc_number] => 08298576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-30
[patent_title] => 'Sustained-release formulations of topiramate'
[patent_app_type] => utility
[patent_app_number] => 11/941475
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8911
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11941475
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/941475 | Sustained-release formulations of topiramate | Nov 15, 2007 | Issued |
Array
(
[id] => 5409623
[patent_doc_number] => 20090123521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Medical devices having coatings for controlled therapeutic agent delivery'
[patent_app_type] => utility
[patent_app_number] => 11/983796
[patent_app_country] => US
[patent_app_date] => 2007-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11732
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123521.pdf
[firstpage_image] =>[orig_patent_app_number] => 11983796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/983796 | Medical devices having coatings for controlled therapeutic agent delivery | Nov 8, 2007 | Issued |
Array
(
[id] => 4859195
[patent_doc_number] => 20080268045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'SUSTAINED RELEASE METHOTREXATE FORMULATIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/937953
[patent_app_country] => US
[patent_app_date] => 2007-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 29772
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20080268045.pdf
[firstpage_image] =>[orig_patent_app_number] => 11937953
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/937953 | SUSTAINED RELEASE METHOTREXATE FORMULATIONS AND METHODS OF USE THEREOF | Nov 8, 2007 | Abandoned |
Array
(
[id] => 4718728
[patent_doc_number] => 20080241250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'IN VIVO BIOREACTORS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 11/937068
[patent_app_country] => US
[patent_app_date] => 2007-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12580
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11937068
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/937068 | IN VIVO BIOREACTORS AND METHODS OF MAKING AND USING SAME | Nov 7, 2007 | Abandoned |
Array
(
[id] => 4964928
[patent_doc_number] => 20080107748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Microcapsules for removing and absorbing a chemical from a mixture'
[patent_app_type] => utility
[patent_app_number] => 11/982917
[patent_app_country] => US
[patent_app_date] => 2007-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1700
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107748.pdf
[firstpage_image] =>[orig_patent_app_number] => 11982917
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/982917 | Microcapsules for removing and absorbing a chemical from a mixture | Nov 4, 2007 | Abandoned |
Array
(
[id] => 4964906
[patent_doc_number] => 20080107726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'COMPOSITIONS COMPRISING BETA-ADRENERGIC RECEPTOR ANTAGONISTS AND DIURETICS'
[patent_app_type] => utility
[patent_app_number] => 11/930467
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3416
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107726.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930467
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930467 | COMPOSITIONS COMPRISING BETA-ADRENERGIC RECEPTOR ANTAGONISTS AND DIURETICS | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4832938
[patent_doc_number] => 20080131485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR PREVENTING RETINAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 11/927613
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11925
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20080131485.pdf
[firstpage_image] =>[orig_patent_app_number] => 11927613
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/927613 | SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR PREVENTING RETINAL DYSFUNCTION | Oct 28, 2007 | Abandoned |
Array
(
[id] => 5422031
[patent_doc_number] => 20090148486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING PULP INFLAMMATIONS CAUSED BY INFECTION OR TRAUMA'
[patent_app_type] => utility
[patent_app_number] => 11/927581
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 34835
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148486.pdf
[firstpage_image] =>[orig_patent_app_number] => 11927581
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/927581 | COMPOSITIONS AND METHODS FOR TREATING PULP INFLAMMATIONS CAUSED BY INFECTION OR TRAUMA | Oct 28, 2007 | Abandoned |
Array
(
[id] => 8457546
[patent_doc_number] => 08293210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-23
[patent_title] => 'Sustained release intraocular implants and methods for preventing retinal dysfunction'
[patent_app_type] => utility
[patent_app_number] => 11/927615
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 11929
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11927615
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/927615 | Sustained release intraocular implants and methods for preventing retinal dysfunction | Oct 28, 2007 | Issued |
Array
(
[id] => 4746566
[patent_doc_number] => 20080091168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'MEDICAL IMPLEMENTS AND MEDICAL IMPLEMENT PRODUCTION METHODS'
[patent_app_type] => utility
[patent_app_number] => 11/870516
[patent_app_country] => US
[patent_app_date] => 2007-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4394
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20080091168.pdf
[firstpage_image] =>[orig_patent_app_number] => 11870516
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/870516 | MEDICAL IMPLEMENTS AND MEDICAL IMPLEMENT PRODUCTION METHODS | Oct 10, 2007 | Abandoned |
Array
(
[id] => 4893036
[patent_doc_number] => 20080102134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'CONTROLLED RELEASE COLOR STABLE PHARMACEUTICAL DOSAGE FORM OF HMG-COA REDUCTASE INHIBITORS, FREE OF ALKALIZING OR BUFFERING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/870744
[patent_app_country] => US
[patent_app_date] => 2007-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3585
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20080102134.pdf
[firstpage_image] =>[orig_patent_app_number] => 11870744
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/870744 | CONTROLLED RELEASE COLOR STABLE PHARMACEUTICAL DOSAGE FORM OF HMG-COA REDUCTASE INHIBITORS, FREE OF ALKALIZING OR BUFFERING AGENTS | Oct 10, 2007 | Abandoned |
Array
(
[id] => 4663224
[patent_doc_number] => 20080254131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'CONTROLLED-RELEASE GALANTAMINE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/870444
[patent_app_country] => US
[patent_app_date] => 2007-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7334
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254131.pdf
[firstpage_image] =>[orig_patent_app_number] => 11870444
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/870444 | Controlled-release galantamine formulations | Oct 10, 2007 | Issued |